MEDA Release: Interim Report, January-March 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Meda has seen a positive start to the year. With an increase in net sales of 5% in the first quarter we are continuing to deliver organic growth of 3% and we are noticing an improvement in the EBITDA margin to 30.0%, despite the strong end to 2013.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC